Origin of research funds |
Title of research project or program |
Duration |
Money allocated |
---|---|---|---|
NIH South African Principal Investigator
|
DREAM |
2022-2024 |
USD 38,000
|
South African Medical Research Council Principal Investigator
|
Self-initiated Research grant |
2022-2024 |
R 200,000 per annum |
South African Medical Research Council Research Supervisor
|
Clinician-Researcher Development Programme (CRP). |
2021 |
R 500,000 per annum |
UP Scholarship of Teaching and Learning (SoTL) grant Principal Investigator
|
A hybrid learning approach to improve final-year medical students’ understanding of and proficiency in health ethics at the University of Pretoria |
2020 |
R 25,000 |
National Research Foundation -Thuthuka grant Research Supervisor
|
Effects of in Utero HIV Exposure on Infant Immune Activation, Function and Regulation |
2020 - 2022 |
R 550,000 |
National Health Laboratory Services Research Trust Principal Investigator
|
Assessment of factors impacting on fetal and infant immunity and growth in HIV and antiretroviral-exposed uninfected children. |
01/03/2018-28/02/2022 |
R 499,649 |
UP Research Development Programme Principal Investigator
|
Assessment of factors impacting on fetal and infant immunity and growth in HIV and antiretroviral-exposed uninfected children. |
01/03/2018-28/02/2019 |
R 50,000 |
NIH: 1R01HD094719-01 Co-investigator
|
Mechanisms controlling the persistence of infectious HIV reservoirs in children. |
08/01/2017–06/30/2022 |
USD 3,176,556 |
International AIDS Society – CIPHER grant Co-investigator
|
Assessment of factors impacting on fetal and infant immunity and growth in HIV and antiretroviral-exposed uninfected children. |
01/11/2018-31/10/2019 |
USD 149,793.82 |
NIAID: 1R01AI108366-01 Sub-investigator
|
Unintended and Intended Implications of HIV Cure: A Social and Ethical Analysis. |
06/15/2013-06/15/2017 |
|
National Research Foundation -Thuthuka grant Principal Investigator
|
Effect of cotrimoxazole on markers of immune activation in HIV-infected patients on ART. |
01/01/2015-12/31/2017 |
R 378,000 |
National Health Laboratory Services Research Trust Principal Investigator
|
The effect of cotrimoxazole on markers of immune activation in HIV-infected patients on highly-active antiretroviral therapy. |
01/01/2015-12/31/2017 |
R 500,000 |
National Research Foundation -Infrastructure funding instruments (NEP/NNEP) Principal Investigator
|
Suspension Bead Array |
2013/14-2020 |
R 1,100,000 |
Delegation of the European Union to South Africa Sub-investigator
|
Drug Resistance Surveillance & Treatment Monitoring Network for the Public Sector HIV Antiretroviral Treatment Programme in the Free State. |
01/31/2008-12/31/2014 |
Euro 8M |
NHLS Research Trust: Development grant |
Interactions of bedaquiline, clofazimine and antiretrovarial agents individually and in combination with human platelets and neutrophils in vitro.
|
2018 |
R 100 000 |
NHLS Research Trust: Development grant |
Investigating the relationship between cigarette smoking and immune markers of platelet activation in HIV-positive participants. |
2020 |
R 100 000 |
NHLS Research Trust: Development grant |
Fibroblast growth factor 21 and growth and differentiation factor 15 as potential systemic biomarkers of mitochondrial toxicity and associations with disease severity and immune suppression in HIV-1infected patients in Tshwane, South Africa.
|
2020 |
R 100 000 |
Poliomyelitis Research Foundation PhD Scholarship 2021
|
Determine and compare the immunological profiles and clinical outcomes by means of flow cytometric and cytokine analysis of both individuals living with HIV and HIV-uninfected patients admitted with COVID-19 to hospital in Tshwane.
|
2021,2022,2023 |
R 55 000 p/a |
NHLS Research Trust: Development grant |
Fibroblast growth factor 21 and growth and differentiation factor 15 as potential systemic biomarkers of mitochondrial toxicity and associations with disease severity and immune suppression in HIV-1infected patients in Tshwane, South Africa.
|
2022 |
R 100 000 |
UP Postgraduate Masters Research bursary |
The impact of inflammatory and metabolic breastmilk profiles associated with maternal HIV on infant growth and development
|
2022 |
R 18 000 |
Poliomyelitis Research Foundation |
The impact of inflammatory and metabolic breastmilk profiles associated with maternal HIV on infant growth and development
|
2023 |
R 40 000 |
UP Postgraduate Masters Research renewal bursary |
The impact of inflammatory and metabolic breastmilk profiles associated with maternal HIV on infant growth and development
|
2023 |
R 20 000 |
National Research Foundation |
The impact of inflammatory and metabolic breastmilk profiles associated with maternal HIV on infant growth and development
|
2023 |
R 112 158 |
Copyright © University of Pretoria 2024. All rights reserved.
Get Social With Us
Download the UP Mobile App